These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Binding of low-density lipoprotein and chylomicron remnants to the hepatic low-density lipoprotein receptor of dogs, rats and rabbits demonstrated by ligand blotting. Failure to detect a distinct chylomicron-remnant-binding protein by ligand blotting. Wade DP, Knight BL, Soutar AK. Eur J Biochem; 1986 Sep 01; 159(2):333-40. PubMed ID: 3019686 [Abstract] [Full Text] [Related]
3. Detection and quantitation of low density lipoprotein (LDL) receptors in human liver by ligand blotting, immunoblotting, and radioimmunoassay. LDL receptor protein content is correlated with plasma LDL cholesterol concentration. Soutar AK, Harders-Spengel K, Wade DP, Knight BL. J Biol Chem; 1986 Dec 25; 261(36):17127-33. PubMed ID: 3782157 [Abstract] [Full Text] [Related]
7. Ligand selectivity of 105 kDa and 130 kDa lipoprotein-binding proteins in vascular-smooth-muscle-cell membranes is unique. Bochkov VN, Tkachuk VA, Philippova MP, Stambolsky DV, Bühler FR, Resink TJ. Biochem J; 1996 Jul 01; 317 ( Pt 1)(Pt 1):297-304. PubMed ID: 8694779 [Abstract] [Full Text] [Related]
8. Visualization of lipoprotein receptors by ligand blotting. Daniel TO, Schneider WJ, Goldstein JL, Brown MS. J Biol Chem; 1983 Apr 10; 258(7):4606-11. PubMed ID: 6300091 [Abstract] [Full Text] [Related]
9. Binding characteristics of reduced hepatic receptors for acetylated low-density lipoprotein and maleylated bovine serum albumin. Ottnad E, Via DP, Sinn H, Friedrich E, Ziegler R, Dresel HA. Biochem J; 1990 Feb 01; 265(3):689-98. PubMed ID: 2154967 [Abstract] [Full Text] [Related]
11. Antipeptide antibody against the human low-density-lipoprotein receptor. Characterization and cross-reactivity with bovine lymphocytes. Agnani G, Delpierre C, Benhamamouch S, Torpier G, Cachera C, Koffigan M, Tartar A, Fruchart JC, Clavey V. Biochem J; 1989 Nov 01; 263(3):753-60. PubMed ID: 2688636 [Abstract] [Full Text] [Related]
12. Low-density lipoprotein receptor point mutation results in expression of both active and inactive surface forms of the same mutant receptor. Fourie AM, Coetzee GA, Gevers W, van der Westhuyzen DR. Biochemistry; 1992 Dec 29; 31(51):12754-9. PubMed ID: 1463746 [Abstract] [Full Text] [Related]
14. Interaction of apolipoprotein B-containing lipoprotein secreted by Hep G2 cells with receptors for low-density lipoprotein. Fuki IV, Menschikov GB, Menschikowski M, Adamova IYu, Repin VS. Biochim Biophys Acta; 1991 Nov 05; 1086(2):237-40. PubMed ID: 1657183 [Abstract] [Full Text] [Related]
18. Unusual forms of low density lipoprotein receptors in hamster cell mutants with defects in the receptor structural gene. Kozarsky KF, Brush HA, Krieger M. J Cell Biol; 1986 May 05; 102(5):1567-75. PubMed ID: 3517003 [Abstract] [Full Text] [Related]
19. Expression of caveolin-1 in hepatic cells increases oxidized LDL uptake and preserves the expression of lipoprotein receptors. Truong TQ, Brodeur MR, Falstrault L, Rhainds D, Brissette L. J Cell Biochem; 2009 Nov 01; 108(4):906-15. PubMed ID: 19718657 [Abstract] [Full Text] [Related]
20. Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity. Noto D, Rizzo M, Barbagallo CM, Cefalù AB, Verde AL, Fayer F, Notarbartolo A, Averna MR. Metabolism; 2006 Oct 01; 55(10):1308-16. PubMed ID: 16979400 [Abstract] [Full Text] [Related] Page: [Next] [New Search]